The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.
about
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from LatencyInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesThe viral etiology of AIDS-associated malignanciesTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaEpstein-Barr virus latent genesEGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionDual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytesEpstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expressionAntiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionInterferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.Human Cytomegalovirus Latency: Approaching the Gordian Knot.The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor InactivationEpstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.Human tumor virus utilizes exosomes for intercellular communication.Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomasA translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF actionInduction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinomaEpstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication.Unique signaling properties of CTAR1 in LMP1-mediated transformation.Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsSKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca(2+) signaling in nasopharyngeal carcinoma cells.Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosisNuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties
P2860
Q24516975-45010E9A-B448-4EDA-891F-FE23FF40C6B7Q24538669-44A1C6FF-4B75-4544-9444-C45719C8540DQ24646670-4E7DB5BD-666C-4C50-A86D-57BE34F5BD84Q24685892-96984D3F-1E99-4D71-9E61-CB72A9DD3F43Q27016002-8AE7B83F-DA7E-4953-BC39-4D26F34301EAQ28082701-A24AF530-41FD-4863-AC2E-4A52A6C8880AQ28551865-E7A2C92E-5798-4961-95FF-3A5943614389Q30979226-F4CCA1B2-2D81-4528-8E05-D136194A22CCQ33641167-7D952092-7CDA-4513-AF66-722751BF40FFQ33777888-AA3162CD-4D62-4D5C-9624-7582F1F26FD2Q33786551-41E70F84-356F-4C07-90E0-CC26D40F1710Q33792860-66D699FE-6F65-4DFF-9535-D2077D7C3A7EQ33809963-D65A5243-B9ED-41A1-B9DE-7BB82E715CD1Q33834888-310767B6-5509-4890-9B53-36F39695BB15Q33866046-3164F9B5-64EB-495B-8577-B508326D4A20Q33870488-21D671D9-6CFE-447F-8F68-5BA1B5753D5BQ33912815-1ECD7A4A-15B7-4EC2-BA5F-A9D79150C15AQ34099074-49EFD0A6-0A8D-49E6-948F-9C445E68ED6BQ34213559-E9E4CC9D-B5D0-4D46-BD37-53D2E1AB0B9EQ34346992-70C3DAD3-B416-4D82-8022-5A479B8E1E24Q34377767-80C123B0-7A44-4729-91F2-F1AF83FBD0E7Q34502958-98153340-360D-4FAF-AEA9-92F7B4648195Q34605336-3AEE0089-736D-4FF7-9D51-B7EA7D17C8A6Q34733314-06355CF5-CDDB-48AC-98D6-13AE25E6AB4FQ35121711-A7657235-7CE1-4DC4-AB2A-445DFF781EF9Q35238447-B1712DDA-11C1-4471-90AF-DA2DB5F71334Q35746620-528BD747-8154-4D3B-A633-FBAB2C251671Q35764233-D753664C-D200-462E-89E6-A40528D36762Q35857669-10993C84-2859-493A-AD9C-4D706694C41BQ35873657-86AA322A-A323-4F7F-B968-6DC332F5C32CQ35875444-E84AD784-D58B-458D-8EA0-BFBCB6682062Q36006767-460EE7F6-3022-4847-AE3B-2025DF503ACAQ36027770-4E80A3C8-89AF-4155-B763-90D05B650A52Q36098869-D7BF067A-309C-4DB8-8934-A54EB19D795FQ36135900-E311D278-386E-4856-823C-A90DB676881BQ36239983-A480B3D8-C996-4992-B5DE-75F769F0BBE2Q36242117-8A48ADC2-23B2-4138-8053-388AEF3CD502Q36670981-49AED81D-A410-426F-97F0-AB225D22099DQ36961875-24112EBD-0873-4B1F-B440-D3F3AE3AE6CFQ37596432-D14CF589-96ED-489F-A09B-9212D5BAA801
P2860
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@ast
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@en
type
label
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@ast
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@en
prefLabel
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@ast
The Epstein-Barr virus latent ...... dermal growth factor receptor.
@en
P2093
P2860
P1433
P1476
The Epstein-Barr virus latent ...... idermal growth factor receptor
@en
P2093
N Raab-Traub
W E Miller
P2860
P304
P407
P577
1995-07-01T00:00:00Z